OnabotulinumtoxinA, Nerve Stimulation Devices, Mirabegron, and Anticholinergics Versus Best Supportive Care for Overactive Bladder: An Updated US Cost-Effectiveness Analysis. (July 2022) - Murray, Brian; Miles-Thomas, Jennifer; Sussman, David; Park, Amy J.; Chermansky, Christopher; Nguyen, Victor; Tung, Amy; Gillard, Patrick; Lalla, Anjana; Nitti, Victor